关注
Erkka Karl Syvälahti
Erkka Karl Syvälahti
Professor, Dept. Pharmacology and Clinical Pharmacology
在 fimnet.fi 的电子邮件经过验证
标题
引用次数
引用次数
年份
The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers
T Pohjalainen, JO Rinne, K Någren, P Lehikoinen, K Anttila, ...
Molecular psychiatry 3 (3), 256-260, 1998
8411998
Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients.
J Hietala, E Syvälahti, K Vuorio, V Räkköläinen, J Bergman, ...
Lancet (London, England) 346 (8983), 1130-1131, 1995
4301995
Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence
J Hietala, C West, E Syvälahti, K Någren, P Lehikoinen, P Sonninen, ...
Psychopharmacology 116, 285-290, 1994
3351994
Association between low activity serotonin transporter promoter genotype and early onset alcoholism with habitual impulsive violent behavior
T Hallikainen, T Saito, HM Lachman, J Volavka, T Pohjalainen, ...
Molecular psychiatry 4 (4), 385-388, 1999
3271999
Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia
J Hietala, E Syvälahti, H Vilkman, K Vuorio, V Räkköläinen, J Bergman, ...
Schizophrenia research 35 (1), 41-50, 1999
3191999
Sex Differences in the Striatal Dopamine D2 Receptor Binding Characteristics in Vivo
T Pohjalainen, JO Rinne, K Någren, E SyvÄlahti, J Hietala
American Journal of Psychiatry 155 (6), 768-773, 1998
3081998
Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism
J Tiihonen, T Hallikainen, H Lachman, T Saito, J Volavka, J Kauhanen, ...
Molecular psychiatry 4 (3), 286-289, 1999
2671999
Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography
J Hietala, E Syvälahti, K Vuorio, K Nägren, P Lehikoinen, U Ruotsalainen, ...
Archives of general psychiatry 51 (2), 116-123, 1994
2501994
Two-year outcome in first-episode psychosis treated according to an integrated model. Is immediate neuroleptisation always needed?
V Lehtinen, J Aaltonen, T Koffert, V Räkköläinen, E Syvälahti
European psychiatry 15 (5), 312-320, 2000
2432000
Decrease in Human Striatal Dopamine D2 Receptor Density with Age: A PET Study with [11C]Raclopride
JO Rinne, J Hietala, U Ruotsalainen, E Säkö, A Laihinen, K Någren, ...
Journal of Cerebral Blood Flow & Metabolism 13 (2), 310-314, 1993
2421993
Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2C receptor
EP Pälvimäki, H Majasuo, A Laakso, M Kuoppamäki, E Syvälahti, BL Roth, ...
Psychopharmacology 126, 234-240, 1996
2351996
Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects
A Laakso, H Vilkman, J Örgen Bergman, M Haaparanta, O Solin, ...
Biological psychiatry 52 (7), 759-763, 2002
2302002
Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind …
BG Appelberg, EK Syvalahti, TE Koskinen, OP Mehtonen, TT Muhonen, ...
Journal of Clinical Psychiatry 62 (6), 448-452, 2001
2112001
The A1 allele of the human D2 dopamine receptor gene is associated with increased activity of striatal L-amino acid decarboxylase in healthy subjects
A Laakso, T Pohjalainen, J Bergman, J Kajander, M Haaparanta, O Solin, ...
Pharmacogenetics and genomics 15 (6), 387-391, 2005
2092005
Clozapine and N-desmethylclozapine are potent 5-HT1C receptor antagonists
M Kuoppamäki, E Syvälahti, J Hietala
European Journal of Pharmacology: Molecular Pharmacology 245 (2), 179-182, 1993
1621993
Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography
A Laakso, H Vilkman, B Alakare, M Haaparanta, J Bergman, O Solin, ...
American Journal of Psychiatry 157 (2), 269-271, 2000
1602000
Personality traits and striatal dopamine synthesis capacity in healthy subjects
A Laakso, E Wallius, J Kajander, J Bergman, O Eskola, O Solin, T Ilonen, ...
American Journal of Psychiatry 160 (5), 904-910, 2003
1422003
Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia
A Laakso, J Bergman, M Haaparanta, H Vilkman, O Solin, E Syvälahti, ...
Schizophrenia research 52 (1-2), 115-120, 2001
1422001
The amygdala and schizophrenia: a volumetric magnetic resonance imaging study in first-episode, neuroleptic-naive patients
CC Joyal, MP Laakso, J Tiihonen, E Syvälahti, H Vilkman, A Laakso, ...
Biological psychiatry 54 (11), 1302-1304, 2003
1202003
Cortical glutamate–dopamine interaction and ketamine-induced psychotic symptoms in man
S Aalto, J Ihalainen, J Hirvonen, J Kajander, H Scheinin, H Tanila, ...
Psychopharmacology 182, 375-383, 2005
1192005
系统目前无法执行此操作,请稍后再试。
文章 1–20